Source:http://linkedlifedata.com/resource/umls/id/C2827405
NCI: A system for scoring myelodysplasia syndrome progression risk, based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood.